• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Communication Services·000892.SZ
Share

H&R Century Union Corporation Stocks

CN¥ 4.52Last Updated 30.09.2026

Issuer Rating

2/7
Performance

Poor

Risk

Considerable

Recommendation

Sell

Market Cap

CN¥ 659.08M

CN¥ 4.52
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

H&R Century Union Corporation, a company based in Chongqing, China, primarily operates within the entertainment industry. Its main business areas involve the creation of drama series and managing the careers of performing artists across China. The company handles all stages of film and television drama projects, from initial planning and development to production, marketing, and ultimately, distribution. Additionally, H&R Century Union provides asset investment management services. Founded in 1997, the organization was previously known as Stellar Megaunion Corp. before officially adopting its current name in February 2017.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

01.10.2026 17:30

Shares of biotech company Capricor had their best day in a month. What inspired investors?

01.10.2026 16:53

From Coke to IMAX: 10 Companies Bloomberg Recommends Watching in the Fourth Quarter

01.10.2026 15:45

Morning in New York: Indices Seek Equilibrium

01.10.2026 15:13

Behind the scenes at the White House, IT company executives criticized Anthropic's CEO for AI alarmism

01.10.2026 14:44

An analyst named two companies that Novo should acquire to compete with Lilly

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026